Cargando…
Effects of Repeated Central Administration of Endothelin Type A Receptor Antagonist on the Development of Neuropathic Pain in Rats
Endothelin-1 (ET-1) predominates in the endothelin family effectively in vascular tone control, mitogenesis, and neuromodulation. Its receptors are widespread in the central nervous system (CNS) associated with endogenous pain control, suggesting an important role of ET-1 in central pain processing....
Autores principales: | Tai, Lydia W., Hung, Victor K. L., Mei, Wei, Qiu, Qiu, Chung, Sookja K., Cheung, C. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773389/ https://www.ncbi.nlm.nih.gov/pubmed/24073407 http://dx.doi.org/10.1155/2013/529871 |
Ejemplares similares
-
Central Administration of C-X-C Chemokine Receptor Type 4 Antagonist Alleviates the Development and Maintenance of Peripheral Neuropathic Pain in Mice
por: Luo, Xin, et al.
Publicado: (2014) -
Crosstalk between astrocytic CXCL12 and microglial CXCR4 contributes to the development of neuropathic pain
por: Luo, Xin, et al.
Publicado: (2016) -
Repeated Sigma-1 Receptor Antagonist MR309 Administration Modulates Central Neuropathic Pain Development After Spinal Cord Injury in Mice
por: Castany, Sílvia, et al.
Publicado: (2019) -
Endothelin and Endothelin Antagonists in Chronic Kidney Disease
por: Kohan, Donald E., et al.
Publicado: (2014) -
Endothelin Receptors and Their Antagonists()()
por: Maguire, Janet J., et al.
Publicado: (2015)